Pydiflumetofen + Fludioxonil is a new fungicide being developed by Syngenta for the control of foliar and soil-borne diseases of ornamental horticulture crops.
Category: Plant Pathology Crop Safety
Mandestrobin Crop Safety – 2018
Mandestrobin is a new systemic and translaminar fungicide being developed by Syngenta for the control of Botrytis and other foliar diseases of ornamental horticulture crops.
Pydiflumetofen + Azoxystrobin + Propiconazole Crop Safety – 2018
Pydiflumetofen + Azoxystrobin + Propiconazole was a new fungicide being developed by Syngenta for the control of leaf spots (Septoria, Cercospora,
Benzovindiflupyr + Azoxystrobin Crop Safety – 2017
In 2013, as part of the crop safety screening for new active ingredients and recently registered fungicides, IR-4 started testing Mural WDG (benzovindiflupyr + azoxystrobin) for
Oxathiapiprolin Crop Safety – 2017
Oxathiapiprolin was registered as Segovis in the United States in 2017 for disease control on ornamental horticulture plants in greenhouse and nurseries. The commercial label contains
Fluensulfone Crop Safety – 2017
Fluensulfone was registered as Nimitz Pro G in the United States in 2016 for nematode control in turf. Between 2012 and 2014, the IR-4 Project completed 13 trials on 8 ornamental horticulture
Metconazole Crop Safety – 2017
Metconazole was registered as Tourney 50WDG in the United States in 2007 as a turf fungicide. In 2010, uses for ornamental horticulture plants in greenhouse, nurseries, and landscapes were added.
Tebuconazole Crop Safety – 2015
Tebuconazole was first registered in 1994 for peanut diseases. Since then its food use label has expanded to several other food crops. The first noncrop registration of Torque 3.6SC (tebuconazole)
Polyoxin D Crop Safety Summary – 2007
Polyoxin D was registered as Endorse in the United States in 2003 as a turf fungicide. In 2005, this label was updated to include applications for certain diseases on ornamental crops.
Ametoctradin + Dimethomorph Crop Safety – 2015
Orvego, registered with EPA on May 21, 2012 is a combination of ametoctradin (FRAC 45) and dimethomorph (FRAC 40). In 2012, IR-4 started testing Orvego (ametoctradin +